Noboru Shinkai

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

M-F Yuen, Yasuhito Tanaka, Noboru Shinkai et al. · Gut · 2007 · 174 citations

Medicine, Genetics, Molecular Genetics +16

Serum hepatitis B core‐related antigen as a treatment predictor of pegylated interferon in patients with <scp>HB</scp>eAg‐positive chronic hepatitis B

Natthaya Chuaypen, Nawarat Posuwan, Sunchai Payungporn et al. · Liver International · 2015 · 88 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Application of a Newly Developed High-Sensitivity HBsAg Chemiluminescent Enzyme Immunoassay for Hepatitis B Patients with HBsAg Seroclearance

Noboru Shinkai, Kentaro Matsuura, Fuminaka Sugauchi et al. · Journal of Clinical Microbiology · 2013 · 73 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection

Noboru Shinkai, Yasuhito Tanaka, E ORITO et al. · Hepatology Research · 2006 · 71 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Influence of Hepatitis B Virus X and Core Promoter Mutations on Hepatocellular Carcinoma among Patients Infected with Subgenotype C2

Noboru Shinkai, Yasuhito Tanaka, Kiyoaki Ito et al. · Journal of Clinical Microbiology · 2007 · 64 citations · Full text

Medicine, Genetics, Molecular Genetics +17